Senti Biosciences Financials - Benzinga

Senti Biosciences Holdings Inc

SNTINASDAQ

Trade with Public

Trade with Public

$0.3293

-0.0137-3.99%

近くで: Sep 25, 5:00 PM EST

$0.3370

0.00772.34%

時間外: Sep 25, 7:59 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

Senti Biosciences Financials

Senti Biosciences (SNTI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Senti Biosciences Q1 EPS $(0.14) Beats $(0.36) Estimate, Sales $16.000K

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.36) by 61.11 percent. This is a 90.07 percent increase over losses of $(1.41) per share from

Benzinga Newsdesk

PRO
Senti Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate, Sales $22.000K Miss $666.667K Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.48) by 11.11 percent. This is a 20.9 percent increase over losses of $(0.67) per share

Benzinga Newsdesk

PRO
Senti Biosciences Q3 EPS $(0.69) Misses $(0.56) Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.56) by 23.21 percent. This is a 89.06 percent increase over losses of $(6.31) per share

Benzinga Newsdesk

PRO
Senti Biosciences Q2 EPS $(0.56) Beats $(0.90) Estimate

Senti Biosciences (NASDAQ:SNTI) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.90) by 37.78 percent. This is a 77.14 percent increase over losses of $(2.45) per share from

Benzinga Newsdesk

PRO
Senti Biosciences Q1 EPS $(1.41) Up From $(2.60) YoY

Benzinga Newsdesk

PRO
Senti Bio Sciences Q4 EPS ($0.67) Up From ($4.19) YoY.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved